Nicolas Heinz von der Höh1, Philipp Pieroh2, Jeanette Henkelmann3, Daniela Branzan4, Anna Völker2, Dina Wiersbicki2, Christoph-Eckhard Heyde2. 1. Department of Orthopaedic, Trauma and Plastic Surgery, University Hospital Leipzig, Liebigstr. 18, 04103, Leipzig, Germany. Nicolas.vonderHoeh@medizin.uni-leipzig.de. 2. Department of Orthopaedic, Trauma and Plastic Surgery, University Hospital Leipzig, Liebigstr. 18, 04103, Leipzig, Germany. 3. Department for Diagnostic and Interventional Radiology, University Hospital Leipzig, Liebigstr. 18, 04103, Leipzig, Germany. 4. Department of Visceral, Transplant, Thorax and Vascular Surgery, University Hospital Leipzig, Liebigstr. 18, 04103, Leipzig, Germany.
Abstract
PURPOSE: To report the challenging therapeutic approach and the clinical outcome of patients with pyogenic spondylodiscitis transmitted due to infected retroperitoneal regions of primary infected mycotic aortic aneurysms (MAAs) or secondary infected aortic stent grafts after endovascular aneurysm repair (EVAR). METHODS: Between 2012 and 2019, all patients suffering from spondylodiscitis based on a transmitted infection after the EVAR procedure were retrospectively identified. Patient data were analysed regarding the time between primary and secondary EVAR infection and spondylodiscitis detection, potential source of infection, pathogens, antibiotic treatment, complications, recovery from infection, mortality, numeric rating scale (NRS), COBB angle and cage subsidence. RESULTS: Fifteen patients with spondylodiscitis transmitted from primary or secondary infected aortic aneurysms after EVAR were included. The median follow-up time was 8 months (range 1-47). Surgery for spondylodiscitis was performed in 12 patients. In 9 patients, the infected graft was treated conservatively. MAAs were treated in 4 patients first with percutaneous aortic stent graft implantation followed by posterior surgery of the infected spinal region in a two-step procedure. Infection recovery was recorded in 11 patients during follow-up. The overall mortality rate was 27% (n = 4). The mean pain intensity improved from an NRS score of 8.4 (3.2-8.3) to 3.1 (1.3-6.7) at the last follow-up. CONCLUSION: EVAR was used predominantly to treat primary infected MAAs. Secondary infected grafts were treated conservatively. Independent of vascular therapy, surgery of the spine led to recovery in most cases. Thus, surgery should be considered for the treatment of EVAR- and MAA-related spondylodiscitis.
PURPOSE: To report the challenging therapeutic approach and the clinical outcome of patients with pyogenic spondylodiscitis transmitted due to infected retroperitoneal regions of primary infected mycotic aortic aneurysms (MAAs) or secondary infected aortic stent grafts after endovascular aneurysm repair (EVAR). METHODS: Between 2012 and 2019, all patients suffering from spondylodiscitis based on a transmitted infection after the EVAR procedure were retrospectively identified. Patient data were analysed regarding the time between primary and secondary EVAR infection and spondylodiscitis detection, potential source of infection, pathogens, antibiotic treatment, complications, recovery from infection, mortality, numeric rating scale (NRS), COBB angle and cage subsidence. RESULTS: Fifteen patients with spondylodiscitis transmitted from primary or secondary infectedaortic aneurysms after EVAR were included. The median follow-up time was 8 months (range 1-47). Surgery for spondylodiscitis was performed in 12 patients. In 9 patients, the infected graft was treated conservatively. MAAs were treated in 4 patients first with percutaneous aortic stent graft implantation followed by posterior surgery of the infected spinal region in a two-step procedure. Infection recovery was recorded in 11 patients during follow-up. The overall mortality rate was 27% (n = 4). The mean pain intensity improved from an NRS score of 8.4 (3.2-8.3) to 3.1 (1.3-6.7) at the last follow-up. CONCLUSION: EVAR was used predominantly to treat primary infected MAAs. Secondary infected grafts were treated conservatively. Independent of vascular therapy, surgery of the spine led to recovery in most cases. Thus, surgery should be considered for the treatment of EVAR- and MAA-related spondylodiscitis.
Authors: Karl Sörelius; Anders Wanhainen; Mia Furebring; Martin Björck; Peter Gillgren; Kevin Mani Journal: Circulation Date: 2016-10-31 Impact factor: 29.690
Authors: P Berger; I Vaartjes; F L Moll; G J De Borst; J D Blankensteijn; M L Bots Journal: Eur J Vasc Endovasc Surg Date: 2015-02-27 Impact factor: 7.069
Authors: Eric Ducasse; Annalisa Calisti; Francesco Speziale; Luigi Rizzo; Maria Misuraca; Paolo Fiorani Journal: Ann Vasc Surg Date: 2004-08-06 Impact factor: 1.466
Authors: Nicolas Heinz von der Hoeh; Anna Voelker; Alex Hofmann; Dirk Zajonz; Ulrich Albert Spiegl; Jan-Sven Jarvers; Christoph-Eckhard Heyde Journal: World Neurosurg Date: 2018-08-23 Impact factor: 2.104
Authors: Heleen D de Koning; Steven M M van Sterkenburg; Maurice E N Pierie; Michel M P J Reijnen Journal: J Vasc Surg Date: 2008-06 Impact factor: 4.268